7Baggers

Vera Therapeutics Inc
(NASDAQ:VERA) 

VERA stock logo

Founded: 2016
CEO / Founder: Marshall Fordyce 
Sector:
Industry:
Pharmaceuticals
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                         
      operating expenses:
    		                     
      research and development
    		86,011,000 59,310,000 56,473,000 58,195,000 41,278,000 33,347,000 40,314,000 29,311,000 23,200,000 20,785,000 16,100,000 16,231,000 25,108,000 26,676,000 19,656,000 10,112,000 12,549,000 12,753,000 3,564,000 3,235,000 2,932,000 
      general and administrative
    		39,121,000 34,896,000 27,459,000 21,946,000 15,916,000 15,567,000 9,487,000 8,032,000 7,912,000 6,243,000 5,656,000 5,739,000 6,150,000 6,905,000 5,588,000 4,945,000 4,472,000 3,832,000 3,688,000 2,614,000 1,784,000 
      total operating expenses
    		125,132,000 94,206,000 83,932,000 80,141,000 57,194,000 48,914,000 49,801,000 37,343,000 31,112,000 27,028,000 21,756,000 21,970,000 31,258,000 33,581,000 25,244,000 15,057,000 17,021,000 16,585,000 7,252,000 5,849,000 4,716,000 
      income from operations
    		-125,132,000 -94,206,000 -83,932,000 -80,141,000 -57,194,000 -48,914,000 -49,801,000 -37,343,000 -31,112,000 -27,028,000 -21,756,000 -21,970,000 -31,258,000 -33,581,000 -25,244,000 -15,057,000 -17,021,000 -16,585,000 -7,252,000 -5,849,000 -4,716,000 
      yoy
    		118.79% 92.60% 68.53% 114.61% 83.83% 80.98% 128.91% 69.97% -0.47% -19.51% -13.82% 45.91% 83.64% 102.48% 248.10% 157.43% 260.92%     
      qoq
    		32.83% 12.24% 4.73% 40.12% 16.93% -1.78% 33.36% 20.03% 15.11% 24.23% -0.97% -29.71% -6.92% 33.03% 67.66% -11.54% 2.63% 128.70% 23.99% 24.02%  
      other income:
    		                     
      interest income
    		6,355,000 5,517,000 5,736,000 6,320,000 6,906,000 6,663,000 4,761,000 5,104,000 4,186,000 1,960,000 2,158,000 2,239,000 1,623,000 894,000 567,000 263,000 26,000 6,000 5,000 2,000 2,000 
      interest expense
    		-1,823,000 -1,904,000 -1,960,000 -1,874,000 -1,792,000 -1,871,000 -1,936,000 -1,912,000 -1,906,000 -1,056,000 -943,000 -914,000 -874,000 -599,000 -147,000 -128,000 -118,000     
      other income
    		-432,000 -503,000 -137,000 -836,000 386,000 698,000 344,000 450,000 453,000 472,000 452,000 511,000 441,000 912,000 347,000 325,000 315,000     
      total other income
    		4,100,000 3,110,000 3,639,000 3,610,000 5,500,000 5,490,000 3,169,000 3,635,000 2,729,000 1,374,000 1,652,000 1,808,000 1,189,000 1,143,000 565,000 204,000 -64,000 -261,000 -359,000 2,412,000 2,000 
      net income
    		-121,032,000 -91,097,000 -80,293,000 -76,531,000 -51,694,000 -43,425,000 -46,632,000 -33,708,000 -28,383,000 -25,655,000 -20,104,000 -20,162,000 -30,069,000 -32,439,000 -24,679,000 -14,853,000 -17,085,000     
      yoy
    		134.13% 109.78% 72.18% 127.04% 82.13% 69.27% 131.95% 67.19% -5.61% -20.91% -18.54% 35.74% 76.00%         
      qoq
    		32.86% 13.46% 4.92% 48.05% 19.04% -6.88% 38.34% 18.76% 10.63% 27.61% -0.29% -32.95% -7.31% 31.44% 66.15% -13.06%      
      other comprehensive income:
    		                     
      change in unrealized gains and losses on marketable securities
    		-942,000 122,000 354,000 -127,000 261,000 -651,000 1,494,000               
      comprehensive loss
    		-121,974,000 -91,192,000 -79,939,000 -76,658,000 -51,433,000 -44,076,000 -45,138,000 -33,985,000 -28,807,000 -25,553,000 -20,037,000 -20,300,000 -29,849,000         
      net income per share
    		-1.69 -1.39 -1.26 -1.2 -0.81 -0.72 -0.85 -0.62 -0.56 -0.58 -0.45 -0.46 -0.8 -1.19 -0.91 -0.55 -0.71 -0.97 -0.36 -0.33 -12.23 
      weighted-average shares used for eps calculation
    		71,476,595 64,233,814 63,847,055 63,789,303 63,671,558 55,326,680 54,898,297 54,728,552 50,971,933 42,707,072 44,363,419 44,269,772 37,667,566 26,570,676 27,215,874 27,078,450 24,227,282 13,435,706 21,265,519 10,499,937  
      other comprehensive loss:
    		                     
      change in fair value of non-marketable equity securities
    		       -7,000 -4,000 -2,000 -15,000 -28,000 -1,000 -64,000 -202,000 -256,000 -287,000 -247,000 -364,000 -281,000  
      change in unrealized gain on marketable securities
    		       -277,000 -424,000    220,000         
      change in unrealized loss on marketable securities
    		         37,250 67,000 -138,000  55,000 -127,000 -140,000 -12,000     
      gain on sale of pnai technology
    		                   2,691,000  
      total loss and other comprehensive loss
    		             -14,224,000 -24,806,000 -14,993,000 -17,097,000     
      restructuring costs
    		                     
      gain on issuance of convertible notes
    		                     
      change in fair value of convertible notes
    		                     
      net loss and comprehensive loss
    		                 -16,847,000 -7,611,000 -3,437,000 -4,714,000 
      weighted-average common shares outstanding, basic and diluted
    		                    385,401 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                          
        assets
      		                    
        current assets:
      		                    
        cash and cash equivalents
      		354,725,000 57,773,000 49,121,000 55,090,000 92,646,000 27,256,000 25,085,000 69,105,000 45,681,000 27,441,000  137,385,000 43,459,000 30,475,000 50,427,000 111,506,000 79,674,000 86,191,000 91,625,000 49,505,000 
        marketable securities
      		359,864,000 439,616,000 507,706,000 534,744,000 548,206,000 326,053,000 359,302,000 334,559,000 115,035,000 132,498,000 147,132,000 59,768,000 71,194,000 83,945,000 81,501,000 39,432,000     
        prepaid expenses and other assets, current
      		14,294,000 13,922,000 14,527,000 16,242,000 10,366,000 10,822,000 10,360,000 12,706,000 11,307,000            
        total current assets
      		728,883,000 511,311,000 571,354,000 606,076,000 651,218,000 364,131,000 394,747,000 416,370,000 172,023,000 171,620,000 190,614,000 204,449,000 125,698,000 124,982,000 142,338,000 157,743,000 82,537,000 89,760,000 95,876,000 51,532,000 
        property and equipment
      		1,374,000 1,155,000 1,151,000 1,062,000 960,000 368,000 155,000 81,000 92,000 34,000 40,000 45,000 51,000 56,000 21,000 16,000     
        operating lease right-of-use assets
      		1,923,000 2,036,000 2,471,000 2,915,000 3,372,000 3,921,000 1,929,000 2,432,000 2,949,000 3,481,000 4,030,000 4,594,000 5,173,000 5,768,000 5,724,000 6,275,000     
        prepaid expenses and other assets, noncurrent
      		2,553,000 3,001,000 3,552,000 114,000 131,000 140,000 460,000 473,000 471,000            
        total assets
      		734,733,000 517,503,000 578,528,000 610,167,000 655,681,000 368,560,000 397,291,000 419,356,000 175,546,000 175,618,000 195,178,000 209,604,000 131,435,000 131,370,000 148,782,000 164,974,000 83,748,000 91,167,000 97,647,000 51,825,000 
        liabilities and stockholders’ equity
      		                    
        current liabilities:
      		                    
        accounts payable
      		21,898,000 17,950,000 13,157,000 9,262,000 7,665,000 4,602,000 4,664,000 5,209,000 11,118,000 12,300,000 13,280,000 5,326,000 11,991,000 7,012,000 7,084,000 7,328,000 1,385,000 964,000 1,723,000 1,440,000 
        operating lease liabilities
      		549,000 473,000 855,000 1,191,000 1,483,000 1,872,000 2,116,000 2,275,000 2,436,000 2,518,000 2,560,000  2,645,000 2,689,000 2,450,000 2,490,000     
        accrued expenses and other liabilities
      		31,008,000                    
        total current liabilities
      		53,455,000 41,880,000 33,554,000 21,894,000 25,371,000 26,464,000 18,418,000 14,543,000 22,303,000 24,621,000 26,835,000 23,529,000 25,600,000 15,920,000 17,279,000 19,969,000 7,690,000 4,042,000 3,771,000 3,753,000 
        long-term debt
      		74,838,000 74,648,000 74,464,000 50,908,000 50,687,000 50,470,000 50,263,000 50,066,000 49,877,000 25,042,000 24,962,000 24,886,000 24,810,000 4,966,000 4,952,000 4,937,000 4,923,000    
        operating lease liabilities, noncurrent
      		1,919,000 2,095,000 2,233,000 2,366,000 2,468,000 2,568,000 455,000 919,000 1,395,000 1,962,000 2,571,000 3,194,000 3,831,000 4,480,000 4,761,000 5,357,000     
        total liabilities
      		130,212,000 118,623,000 110,251,000 75,168,000 78,526,000 79,502,000 69,422,000 65,814,000 73,861,000 51,911,000 54,655,000 51,895,000 54,527,000 25,652,000 27,278,000 30,549,000 14,156,000 5,690,000 5,492,000 5,565,000 
        stockholders’ equity
      		                    
        class a common stock, 0.001 par value...
      		71,000 64,000 64,000 64,000 64,000 55,000 55,000 54,000 44,000 44,000 44,000 44,000 28,000 28,000 27,000 27,000 21,000 21,000 21,000  
        additional paid-in capital
      		1,364,529,000 1,067,703,000 1,057,161,000 1,047,225,000 1,037,948,000 705,784,000 699,457,000 691,146,000 410,492,000 407,185,000 403,964,000 400,850,000 290,216,000 286,642,000 277,623,000 275,551,000 193,627,000 192,665,000 191,732,000 2,845,000 
        accumulated other comprehensive income
      		786,000 881,000 527,000 654,000 393,000 1,044,000 -450,000 -173,000             
        accumulated deficit
      		-760,865,000 -669,768,000 -589,475,000 -512,944,000 -461,250,000 -417,825,000 -371,193,000 -337,485,000 -309,102,000 -283,447,000 -263,343,000 -243,181,000 -213,112,000 -180,673,000 -155,994,000 -141,141,000 -124,056,000 -107,209,000 -99,598,000 -96,161,000 
        total stockholders’ equity
      		604,521,000 398,880,000 468,277,000 534,999,000 577,155,000 289,058,000 327,869,000 353,542,000 101,685,000 123,707,000 140,523,000 157,709,000 76,908,000 105,718,000 121,504,000 134,425,000 69,592,000 85,477,000 92,155,000  
        total liabilities and stockholders’ equity
      		734,733,000 517,503,000 578,528,000 610,167,000 655,681,000 368,560,000 397,291,000 419,356,000 175,546,000 175,618,000 195,178,000 209,604,000 131,435,000 131,370,000 148,782,000 164,974,000     
        accrued expenses and other liabilities, current
      		 23,457,000 19,542,000 11,441,000 16,223,000 19,990,000 11,638,000 7,059,000 8,749,000            
        preferred stock, 0.001 par value...
      		                    
        accrued expenses and other liabilities, noncurrent
      		      286,000 286,000 286,000            
        restricted cash, noncurrent
      		            293,000 293,000 293,000 293,000 293,000 293,000 293,000 293,000 
        non-marketable equity securities
      		        11,000 13,000 29,000 57,000 58,000 122,000 324,000 580,000 867,000 1,114,000 1,478,000  
        accumulated other comprehensive gain
      		        251,000            
        prepaid expenses and other current assets
      		         11,681,000 9,593,000 7,296,000  10,562,000 10,410,000 6,805,000  3,569,000 4,201,000 1,977,000 
        prepaid expenses and other noncurrent assets
      		         470,000 465,000 166,000  149,000 82,000 67,000     
        accrued expenses and other current liabilities
      		         9,803,000 10,995,000 15,601,000 10,964,000 6,219,000 7,745,000 10,151,000 5,928,000 2,711,000 1,688,000 1,798,000 
        accrued and other noncurrent liabilities
      		         286,000 287,000 286,000 286,000 286,000 286,000 286,000 286,000 286,000 286,000 286,000 
        accumulated other comprehensive loss
      		         -75,000 -142,000 -4,000 -224,000 -279,000 -152,000 -12,000     
        cash, cash equivalents and short-term marketable securities
      		          33,889,000          
        restricted cash
      		           293,000         
        operating lease liabilities, current
      		           2,602,000         
        prepaid expenses and other current assets, current
      		            11,045,000    2,863,000    
        prepaid expenses and other current assets, noncurrent
      		            162,000    51,000    
        restructuring liability, current
      		                377,000 367,000 360,000 515,000 
        restructuring liability, noncurrent
      		                1,257,000 1,362,000 1,435,000 1,526,000 
        class b non-voting common stock, 0.001 par value...
      		                    
        restructuring liability
      		                    
        restricted cash, current
      		                  50,000 50,000 
        liabilities, redeemable convertible preferred stock, and stockholders’ equity
      		                    
        commitments and contingencies
      		                    
        redeemable convertible preferred stock, 0.001 par value...
      		                   139,576,000 
        total liabilities, redeemable convertible preferred stock, and stockholders’ equity
      		                83,748,000 91,167,000 97,647,000  
        liabilities, redeemable convertible preferred stock, and stockholders’ deficit
      		                    
        stockholders’ deficit
      		                    
        total stockholders’ deficit
      		                   -93,316,000 
        total liabilities, redeemable convertible preferred stock, and stockholders’ deficit
      		                   51,825,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                            
          cash flows from operating activities
        		                    
          net loss
        		-91,097,000 -80,293,000 -76,531,000 -51,694,000 -43,425,000 -46,632,000 -33,708,000 -28,383,000 -25,655,000 -20,104,000 -20,162,000 -30,069,000 -32,439,000 -24,679,000 -14,853,000 -17,085,000 -16,847,000 -7,611,000 -3,437,000 -4,714,000 
          adjustments to reconcile net loss to net cash from operating activities:
        		                    
          depreciation and amortization
        		135,000 129,000 119,000 85,000 55,000 24,000               
          accretion of discount and amortization of premium on debt securities
        		-1,109,000 -1,451,000                   
          accretion of loan exit fee and amortization of loan costs
        		637,000 843,000 156,000 221,000 217,000 207,000               
          reduction in the carrying amount of operating lease right-of-use assets
        		113,000 435,000 444,000 457,000 548,000 496,000 503,000 517,000 532,000 549,000 564,000 579,000 595,000 561,000 551,000 564,000     
          stock-based compensation
        		10,965,000 9,745,000 9,472,000 7,744,000 6,217,000 5,588,000 4,873,000 4,124,000 3,221,000 2,923,000 2,682,000 2,667,000 2,748,000 2,452,000 2,025,000 1,662,000 962,000 933,000 713,000 404,000 
          payment of vt-109 license fee
        		0 0 50,000 750,000                 
          changes in operating assets and liabilities:
        		                    
          prepaid expense and other current assets
        		-372,000 606,000 1,714,000 -5,876,000 496,000 -1,843,000 2,720,000 -392,000 809,000 -2,087,000 -2,298,000 3,749,000 -482,000 -154,000   706,000 632,000 -3,517,000 -127,000 
          other assets
        		1,000 -108,000 141,000 17,000 9,000 320,000 13,000 9,000 -1,000 -4,000 -299,000 -5,000 -13,000 -66,000 -303,000 271,000     
          accounts payable
        		3,625,000 4,793,000 3,895,000 1,597,000 3,063,000 -62,000 -545,000 -5,909,000 -1,182,000 -980,000 7,954,000 -6,665,000 4,979,000 -72,000 -244,000 5,943,000 420,000 -759,000 1,012,000 -198,000 
          accrued and other current liabilities
        		      4,579,000 -1,690,000 -1,054,000 -1,192,000 -4,606,000 4,637,000 4,745,000 474,000 -2,406,000 4,223,000 3,217,000 1,023,000 84,000 1,069,000 
          operating lease liabilities
        		-100,000 -520,000 -469,000 -394,000 -529,000 -618,000 -623,000 -637,000 -649,000 -651,000 -665,000 -680,000 -693,000 -647,000 -636,000 -626,000     
          net cash from operating activities
        		-69,994,000 -61,906,000 -54,798,000 -54,406,000 -39,182,000 -36,885,000 -24,782,000 -33,830,000 -25,144,000 -22,973,000 -17,772,000 -26,292,000 -21,162,000 -18,420,000 -19,033,000 -8,981,000 -6,438,000 -5,484,000 -7,665,000 -4,121,000 
          capital expenditures
        		-102,000 -133,000 -208,000 -187,000 -645,000 -238,000 0 0 0 0 0  0 -38,000 -6,000 -18,000 0 0 0  
          free cash flows
        		-70,096,000 -62,039,000 -55,006,000 -54,593,000 -39,827,000 -37,123,000 -24,782,000 -33,830,000 -25,144,000 -22,973,000 -17,772,000  -21,162,000 -18,458,000 -19,039,000 -8,999,000 -6,438,000 -5,484,000 -7,665,000  
          cash flows from investing activities
        		                    
          purchase of property and equipment
        		-102,000 -133,000 -208,000 -187,000 -645,000 -238,000       0 -38,000 -6,000 -18,000     
          purchase of marketable securities
        		-24,499,000 -98,696,000 -97,259,000 -89,992,000 -294,015,000 -72,945,000 -81,088,000 -254,967,000 -53,200,000 -28,672,000 -108,849,000 -34,209,000 -10,563,000 -40,403,000 -58,087,000 -39,437,000     
          proceeds from maturities of marketable securities
        		105,265,000 168,590,000 126,061,000 106,246,000 73,277,000 111,500,000 58,500,000 31,681,000 71,819,000 44,900,000 22,400,000 36,900,000 24,000,000 38,001,000       
          proceeds from sale of marketable securities
        		    0 0 0 4,000,000 0 0 0 9,543,000         
          net cash from investing activities
        		80,664,000 69,761,000 28,544,000 15,317,000 -221,383,000 38,317,000 -22,677,000 -219,286,000 18,556,000 16,228,000 -86,449,000 12,234,000 13,437,000 -2,440,000 -42,094,000 -39,455,000 -5,000,000 0   
          cash flows from financing activities
        		                    
          proceeds from exercise of stock options and employee stock purchase plan
        		4,187,000 797,000 464,000 1,533,000 2,311,000 752,000 3,439,000 6,911,000 87,000 297,000 432,000 240,000 827,000 975,000 47,000 234,000     
          proceeds from refinancing under loan and security agreement
        		0 0                   
          payment of deferred issuance costs related to unfunded loan commitments
        		0 0                   
          proceeds from short swing settlement
        		    0 0 0 37,000             
          proceeds from borrowings, net of costs
        		                    
          repurchase of common stock
        		    0                
          proceeds from issuance of common stock in follow-on offerings
        		                    
          payment of issuance costs and underwriting fees related to follow-on offerings
        		                    
          net cash from financing activities
        		286,282,000 797,000 20,285,000 1,533,000 325,955,000 739,000 3,439,000 276,540,000 24,828,000 297,000 432,000 107,984,000 20,709,000 908,000 48,000 80,268,000 4,921,000 0 48,989,000 -28,000 
          net increase in cash and cash equivalents
        		   -37,556,000                 
          cash and cash equivalents, beginning of year
        		                    
          cash and cash equivalents, end of year
        		                    
          supplemental disclosure of cash flow information
        		                    
          cash paid for interest expense
        		1,716,000 1,766,000 1,657,000 1,581,000 1,662,000 1,736,000 1,734,000 1,520,000    3,253,000    104,000     
          purchases of property and equipment included in accounts payable
        		                    
          follow-on offering costs included in accounts payable
        		                    
          follow-on offering costs included in accrued and other liabilities
        		                    
          accrued and other liabilities
        		 3,915,000 8,101,000 -4,782,000 -3,767,000                
          proceeds from issuance of common stock in follow-on offering
        		     0 0 287,500,000             
          payment of issuance costs and underwriting fees related to follow-on offering
        		                    
          net decrease in cash and cash equivalents
        		 8,652,000    2,171,000               
          cash and cash equivalents, beginning of period
        		 0 0 92,646,000  0               
          cash and cash equivalents, end of period
        		 8,652,000 -5,969,000 55,090,000  2,171,000               
          addition to right-of-use assets obtained from operating lease liabilities
        		                    
          accretion of discount and amortization of premium on purchase of debt securities
        		   -2,531,000 -2,066,000 -2,431,000               
          receivable on exercise of stock options
        		       13,000             
          payment of costs and underwriting discounts and commissions related to follow-on offering
        		     0 0 -17,908,000 0 0 0 -7,256,000 67,000        
          cash paid for operating leases
        		     815,000 764,000 764,000 762,000 746,000 746,000 746,000 743,000 680,000 655,000 656,000     
          depreciation, amortization and accretion
        		       -1,469,000 -1,167,000 -1,442,000 -971,000 -506,000 -597,000 -152,000 -106,000 9,000 32,000 59,000 50,000 35,000 
          net increase in cash and cash equivalents and restricted cash
        		       23,424,000    93,926,000 12,984,000 -19,952,000 -61,079,000 31,832,000 -6,517,000 -5,484,000 42,120,000 -4,149,000 
          cash, cash equivalents and restricted cash, beginning of period
        		       45,681,000  0 0 43,752,000  0 0 79,967,000  0 0 53,997,000 
          cash, cash equivalents and restricted cash, end of period
        		       69,105,000  -6,448,000 -103,789,000 137,678,000  -19,952,000 -61,079,000 111,799,000  -5,484,000 42,120,000 49,848,000 
          reconciliation of cash and cash equivalents and restricted cash to the balance sheets
        		                    
          cash and cash equivalents
        		       69,105,000 18,240,000 -6,448,000 -103,496,000 137,385,000 12,984,000 -19,952,000 -61,079,000 111,506,000 -6,517,000 -5,434,000 42,120,000 49,505,000 
          restricted cash
        		           293,000 0 0 0 293,000 0 -50,000 0 343,000 
          total cash and cash equivalents and restricted cash
        		       69,105,000 18,240,000 -6,448,000 -103,789,000 137,678,000 12,984,000 -19,952,000 -61,079,000 111,799,000  -5,484,000 42,120,000 49,848,000 
          issuance of class a common stock for licensing payment, net of costs
        		                    
          change in fair value of non-marketable equity securities
        		        2,000 15,000 29,000 1,000 64,000 202,000   247,000 364,000   
          proceeds from issuance of class a common stock in follow-on offering
        		        0 0 0 115,000,000 -1,000        
          cash, cash equivalents and restricted cash, beginning of year
        		                    
          cash, cash equivalents and restricted cash, end of year
        		                    
          cash paid for interest
        		        853,000 863,000   559,000 119,000       
          issuance of class a common stock in payment of licensing fees
        		                    
          issuance of class a common stock for licensing payment
        		                    
          net decrease in cash and cash equivalents and restricted cash
        		         -6,448,000           
          issuance of class a common stock in payment of accrued development milestone
        		                    
          payment for mau868 asset purchase
        		                    
          restructuring payments
        		                -124,000 -125,000 -160,000 -590,000 
          gain on sale of pnai technology
        		                0 0   
          proceeds from sale of pnai technology
        		                0 0   
          proceeds from issuance of class a common stock upon initial public offering, net of underwriting discounts and commissions
        		                0 0   
          payment of offering costs related to initial public offering
        		                0 0   
          reclassification of redeemable convertible preferred stock into common stock upon initial public offering
        		                 0   
          non-marketable equity securities received as partial proceeds from sale of pnai technology
        		                 0   
          lease assignment
        		                 0   
          liability assumed in connection with mau868 asset purchase
        		                    
          payment of costs related to initial public offering
        		                    
          reclassification of redeemable convertible preferred stock into class a common stock and class b common stock upon initial public offering
        		                    
          prepaid expenses and other current assets
        		               -3,942,000     
          proceeds from issuance of class a common stock offering, net of underwriting discounts and commissions
        		               86,130,000     
          payment of costs related to underwritten follow-on offering
        		               -6,096,000     
          payment of deferred offering costs
        		                   -369,000 
          payment on capital lease obligations
        		                   -1,000 
          deferred offering costs included in accounts payable
        		                   729,000 
          deferred offering costs included in accrued and other current liabilities
        		                   195,000 
          impairment loss on property and equipment and intangible asset
        		                    
          issuance of series c redeemable convertible preferred stock for license
        		                    
          non-cash interest expense on convertible notes
        		                    
          issuance costs for convertible notes
        		                    
          gain on issuance of convertible notes
        		                    
          change in fair value of convertible notes
        		                    
          other liabilities
        		                    
          proceeds from the sale of property and equipment
        		                    
          proceeds from exercise of stock options
        		                0 0 208,000 342,000 
          proceeds from issuance of series c redeemable convertible preferred stock
        		                    
          payment of issuance costs related to issuance of redeemable convertible preferred stock
        		                    
          proceeds from issuance of convertible notes
        		                    
          payment of issuance costs related to convertible notes
        		                    
          payment issuance costs related to convertible promissory notes